Share

September 29, 2015; 85 (13) Article

Type 2 diabetes mellitus and biomarkers of neurodegeneration

Chris Moran, Richard Beare, Thanh G. Phan, David G. Bruce, Michele L. Callisaya, Velandai Srikanth
First published September 2, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001982
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
666

Share

Article Information

vol. 85 no. 13 1123-1130
DOI: 
https://doi.org/10.1212/WNL.0000000000001982
PubMed: 
26333802
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 26, 2015
  • Accepted in final form June 3, 2015
  • First Published September 2, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Chris Moran, MBBCh,
    2. Richard Beare, PhD,
    3. Thanh G. Phan, PhD,
    4. David G. Bruce, MD,
    5. Michele L. Callisaya, PhD and
    6. Velandai Srikanth, PhD
    7. On behalf of the Alzheimer's Disease Neuroimaging Initiative (ADNI)
  1. Chris Moran, MBBCh,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer?s Australia Dementia Research Foundation Scholarship.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Richard Beare, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Thanh G. Phan, PhD,
    4. Scientific Advisory Boards:

    1. Advisory Board for Genzyme

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Associate Editor, Frontiers in Neurology (Stroke subsection)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Advisory Board for Genzyme

    Speakers' Bureaus:

    1. Genzyme; Bayer; Boehringer Ingelheim; Pfizer, BMS

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. David G. Bruce, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Michele L. Callisaya, PhD and
    6. Scientific Advisory Boards:

    1. Royal Hobart Hospital Research Foundation Scientific Advisory Committee

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Pfizer pharmaceuticals for contributing to a pain education resource for General Practitioners

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHRMC Early Career Fellowship 2012-15 1034483

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer Australia Dementia Research Foundation Royal Hobart Hospital Research Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Velandai Srikanth, PhD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) International Journal of Stroke, 2013, (2) Frontiers of Neurology, 2014

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Health and Medical Research Council of Australia, grants 403000, 491109, 606544' years 2006 till present.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

    1. From the Stroke and Ageing Research Group (C.M., T.G.P., V.S.), Vascular Brain Ageing Division, Department of Medicine, School of Clinical Sciences, Monash University, Melbourne; Neurosciences (C.M., T.G.P., V.S.), Monash Medical Centre, Monash Health, Melbourne; Caulfield General Medical Centre (C.M.), Alfred Health, Melbourne; Developmental Imaging (R.B.), Murdoch Children's Research Institute, Melbourne; School of Medicine and Pharmacology (D.G.B.), Fremantle Hospital, University of Western Australia; and Menzies Research Institute Tasmania (M.L.C., V.S.), University of Tasmania, Hobart, Australia.
    1. Correspondence to Dr. Srikanth: velandai.srikanth{at}monash.edu
    View Full Text

    Article usage

    Article usage: September 2015 to April 2022

    AbstractFullPdfSource
    Sep 201535595162Highwire
    Oct 201511724164Highwire
    Nov 2015425728Highwire
    Dec 2015230511Highwire
    Jan 20162121315Highwire
    Feb 2016177712Highwire
    Mar 20161391312Highwire
    Apr 201611576Highwire
    May 20167933Highwire
    Jun 201610464Highwire
    Jul 20169247Highwire
    Aug 201612155Highwire
    Sep 201614144Highwire
    Oct 201616324Highwire
    Nov 20169738Highwire
    Dec 20169823Highwire
    Jan 201722045Highwire
    Feb 20178312Highwire
    Mar 20178433Highwire
    Apr 201710001Highwire
    May 201716822Highwire
    Jun 20178124Highwire
    Jul 201711056Highwire
    Aug 201710811Highwire
    Sep 201710211Highwire
    Sep 2017142421pmc
    Oct 201720500Highwire
    Oct 2017255045pmc
    Nov 201719314Highwire
    Nov 2017124239pmc
    Dec 201711865Highwire
    Jan 201815500Highwire
    Feb 20189302Highwire
    Mar 201814914Highwire
    Apr 201815902Highwire
    Apr 2018163233pmc
    May 201816911Highwire
    Jun 201824834Highwire
    Jun 2018102325pmc
    Jul 201810813Highwire
    Aug 20184702Highwire
    Aug 2018162630pmc
    Sep 20184914Highwire
    Oct 20189224Highwire
    Nov 201813804Highwire
    Dec 20186700Highwire
    Jan 20197641Highwire
    Feb 20197411Highwire
    Mar 20197633Highwire
    Apr 20197825Highwire
    May 20197022Highwire
    Jun 20194303Highwire
    Jul 20196546Highwire
    Aug 20197041Highwire
    Sep 20195821Highwire
    Oct 20198411Highwire
    Nov 20197915Highwire
    Dec 20193441Highwire
    Jan 20204461Highwire
    Feb 20205611Highwire
    Mar 20206220Highwire
    Apr 20208311Highwire
    May 20205013Highwire
    Jun 20205932Highwire
    Jul 20202510Highwire
    Aug 20206021Highwire
    Sep 202010824Highwire
    Oct 20206201Highwire
    Nov 202010722Highwire
    Dec 20204500Highwire
    Jan 20218731Highwire
    Feb 20218711Highwire
    Mar 20219600Highwire
    Apr 20218640Highwire
    May 20219711Highwire
    Jun 202110241Highwire
    Jul 20219242Highwire
    Aug 20217332Highwire
    Sep 20215521Highwire
    Oct 20216730Highwire
    Nov 20216100Highwire
    Dec 20217021Highwire
    Jan 20229922Highwire
    Feb 20225532Highwire
    Mar 20229330Highwire
    Apr 20227531Highwire

    Cited By...

    Disputes & Debates: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Topics Discussed

    Alert Me